Literature DB >> 2476396

Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

J A Whittum-Hudson1, H R Taylor.   

Abstract

Antigen-specific responses to chlamydiae have been demonstrated with lymphocytes isolated from the conjunctiva after primary ocular infection and after topical challenge of chlamydia-immune cynomolgus monkeys with noninfectious, Triton X-100-extracted antigen. Proliferative to viable elementary bodies homologous to the original infecting serovar were demonstrated. In addition, in vitro production of antichlamydial antibody by conjunctival B cells was demonstrated by enzyme-linked immunosorbent assay of culture supernatants collected after 7 to 21 days of culture. These findings demonstrate that antigen-specific lymphocytes appear in the conjunctiva as a result of ocular chlamydial infection and that a noninfectious chlamydial antigen stimulates their reappearance or expansion at the site of original infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476396      PMCID: PMC260758          DOI: 10.1128/iai.57.10.2977-2983.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis.

Authors:  E S Murray; L T Charbonnet; A B MacDonald
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

2.  Chlamydia trachomatis stimulates human peripheral blood B lymphocytes to proliferate and secrete polyclonal immunoglobulins in vitro.

Authors:  J Bard; D Levitt
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

3.  An animal model for cicatrizing trachoma.

Authors:  H R Taylor; R A Prendergast; C R Dawson; J Schachter; A M Silverstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-09       Impact factor: 4.799

4.  Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein.

Authors:  H D Caldwell; L J Perry
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

5.  Proliferative human T cell responses to Chlamydia trachomatis in vitro.

Authors:  E Qvigstad; K Skaug; E Thorsby
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-06

6.  Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans.

Authors:  R C Brunham; D H Martin; C C Kuo; S P Wang; C E Stevens; T Hubbard; K K Holmes
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

7.  Human cell-mediated immune responses to chlamydial antigens.

Authors:  L Hanna; L Schmidt; M Sharp; D P Stites; E Jawetz
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  An animal model of trachoma II. The importance of repeated reinfection.

Authors:  H R Taylor; S L Johnson; R A Prendergast; J Schachter; C R Dawson; A M Silverstein
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-10       Impact factor: 4.799

9.  Analysis of the human serological response to proteins of Chlamydia trachomatis.

Authors:  W J Newhall; B Batteiger; R B Jones
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.

Authors:  R P Morrison; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  3 in total

1.  Chlamydial heat shock proteins and trachoma.

Authors:  H R Taylor; I W Maclean; R C Brunham; S Pal; J Whittum-Hudson
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection.

Authors:  S Pal; H R Taylor; R B Huneke; R A Prendergast; J A Whittum-Hudson
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

3.  Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections.

Authors:  D C Mabey; M J Holland; N D Viswalingam; B T Goh; S Estreich; A Macfarlane; H M Dockrell; J D Treharne
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.